Urol. praxi. 2022;23(2):80-84 | DOI: 10.36290/uro.2022.017
Percutaneous thermoablation is an alternative method of treatment for localized renal tumors (T1a). Its application is mainly in elderly polymorbid patients who are not candidates for surgery. The postoperative outcome in terms of overall survival at 1 year is similar in patients after thermoablation and resection. Overall survival at longer interval is better in the resection group compared with the thermoablation group. Surgical management of this group of tumors remains the method of choice.
Received: March 7, 2022; Revised: March 29, 2022; Accepted: March 29, 2022; Prepublished online: March 29, 2022; Published: June 1, 2022 Show citation